Evidence map›Paper›PMID 26389930›Full record

ArticleInternational journal of environmental research and public health2015

A Multiscale Mapping Assessment of Lake Champlain Cyanobacterial Harmful Algal Blooms.

Nathan Torbick, Megan Corbiere

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. BMAA and Neurodegenerative Illness.Neurotoxicity research · 2018
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan TorbickApplied Geosolutions, Newmarket, New Hampshire, NH 03857, USA. ntorbick@appliedgeosolutions.com.
Megan CorbiereApplied Geosolutions, Newmarket, New Hampshire, NH 03857, USA. mcorbiere@appliedgeosolutions.com.

Funding

CyanoMap: Mapping inland lake quality and Amyotrophic lateral sclerosis risk factR44ES022103 · NIEHS · APPLIED GEOSOLUTIONS, LLC · PI TORBICK, NATHAN · 2014 to 2015
$934k
NIEHS NIH HHS R44 ES022103NIEHS NIH HHS R44 ES022103-03
6 · The paper itself

Abstract

Lake Champlain has bays undergoing chronic cyanobacterial harmful algal blooms that pose a public health threat. Monitoring and assessment tools need to be developed to support risk decision making and to gain a thorough understanding of bloom scales and intensities. In this research application, Landsat 8 Operational Land Imager (OLI), Rapid Eye, and Proba Compact High Resolution Imaging Spectrometer (CHRIS) images were obtained while a corresponding field campaign collected in situ measurements of water quality. Models including empirical band ratio regressions were applied to map chlorophylla and phycocyanin concentrations; all sensors performed well with R² and root-mean-square error (RMSE) ranging from 0.76 to 0.88 and 0.42 to 1.51, respectively. The outcomes showed spatial patterns across the lake with problematic bays having phycocyanin concentrations >25 μg/L. An alert status metric tuned to the current monitoring protocol was generated using modeled water quality to illustrate how the remote sensing tools can inform a public health monitoring system. Among the sensors utilized in this study, Landsat 8 OLI holds the most promise for providing exposure information across a wide area given the resolutions, systematic observation strategy and free cost.

Indexed as

CyanobacteriaEnvironmental MonitoringHarmful Algal BloomLakesModels, TheoreticalWater Qualitychlorophyll-acyanobacterial harmful algal bloomsLake ChamplainLandsat 8 OLIphycocyaninProba CHRISRapidEyewater quality

Identifiers

PMID26389930
PMCPMC4586691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.